Product Information
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB is a generic product labeled by Cipla USA Inc., priced at $0.6002 per EA under NDC 69097020902. Its NADAC has been published 180 times since Jun 2, 2021.
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEStrength
200; 300 mg/1; mg/1
Manufacturer
Cipla USA Inc.NDC
69097020902
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
10/23/2024
Active Ingredients
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA090958On Market Since
3/30/2021
Pharmacological Classes
Price Statistics
The NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB has been published 180 times since Jun 2, 2021, and over the history we have for it it has declined 49.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6002 per EA |
|---|---|
| All-time high | $1.5055 (Aug 11, 2021) |
| All-time low | $0.4258 (May 22, 2024) |
| Median price | $0.5934 |
| Average price | $0.6903 |
| Largest weekly change | +37.3% (Jun 19, 2024) |
| Weeks tracked | 180 |
| Tracking since | Jun 2, 2021 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB, manufactured by Cipla USA Inc., is $0.6002 per EA (NDC 69097020902), effective Nov 6, 2024.
How has the price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB changed over time?
Over the history we have for it, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB has declined 49.1%. It has been tracked across 180 weekly CMS publications since Jun 2, 2021.
What are the highest and lowest recorded NADAC prices for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
Since Jun 2, 2021, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB has ranged from a low of $0.4258 (May 22, 2024) to a high of $1.5055 (Aug 11, 2021), with a median of $0.5934 per EA.
Are there cheaper alternatives to EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB, is $0.5694 per EA — about 5% below EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB.
Who manufactures EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB (NDC 69097020902) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification